SEQUENT SCIENTIFIC LTD. - 512529 - Closure of Trading Window
The Trading Window for all Connected Persons/Designated Persons and their immediate relatives to deal in securities of the Company shall remain closed from Monday, January 01, 2024 till 48 hours after declaration of Unaudited Financial Results of the Company for the quarter and nine months ending on December 31, 2023. SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
We wish to inform you that Mr. Krunal Shah has resigned from the position of Company Secretary & Compliance Officer due to personal reasons. He will continue in his role till the close of business hours of February 15, 2024. SEQUENT SCIENTIFIC LTD. - 512529 - Reply To Clarification Sought By BSE
Reply to clarification sought by BSE SEQUENT SCIENTIFIC LTD. - 512529 - Clarification sought from Sequent Scientific Ltd
The Exchange has sought clarification from Sequent Scientific Ltd on November 28, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Unaudited Financials (Standalone and Consolidated) for Quarter and Half Year ended September 30 2023 SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
The audio recording of the earnings call and earnings presentation made on November 07, 2023, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023, is available on the Company's website. SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation on Unaudited standalone and consolidated financials of quarter and half year ended September 30, 2023 SEQUENT SCIENTIFIC LTD. - 512529 - Appointment Of Chief Financial Officer Of The Company
Appointment of Mr. Saurav Bhala as Chief Financial Officer of the Company
